Search results

67 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Located in Newsroom / UNC Lineberger in the News
Located in Newsroom / UNC Lineberger in the News
Located in Newsroom / UNC Lineberger in the News
UNC Lineberger expands cancer survivors’ program to more N.C. locations
Through the N.C. Cancer Survivorship Provider Action Network (NC-CSPAN), cancer survivors and their loved ones can participate in a free, four-week educational program on nutrition, exercise, coping with stress and medical care. The program seeks to engage survivors to smooth the transition from active treatment.
Located in News
UNC analysis shows advantage for picture-based cigarette pack warnings over text warnings
A University of North Carolina at Chapel Hill analysis published today in the journal Tobacco Control synthesized the results of 37 different experiments comparing picture-based and text warnings, finding that picture-based warnings were more effective than text warnings on 20 of 25 different outcome measures.
Located in News
Noar, Brewer, Ribisl publish in Journalism & Mass Communication Quarterly
UNC Lineberger members Seth Noar, PhD, Noel T. Brewer, PhD, and Kurt M. Ribisl, PhD, published a paper in Journalism & Mass Communication Quarterly that examined the results of 22 different studies that looked at the impact of cigarette pack warnings.
Located in Newsletters / / Honors and Awards / 2016
Chen discussant at ASTRO Annual Meeting plenary session
Ronald C. Chen, MD, MPH, a UNC Lineberger member and associate professor in the UNC School of Medicine Department of Radiation Oncology, was a discussant in the plenary session of the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO) on Sept. 26.
Located in Newsletters / / Honors and Awards / 2016
Payments linked to higher odds of doctors prescribing certain cancer drugs
In preliminary findings presented at the American Society of Clinical Oncology Annual Meeting 2017, researchers show that when physicians had to choose between multiple, on-patent drugs for metastatic kidney cancer and chronic myeloid leukemia, they were more likely to prescribe drugs from companies they had received general payments from.
Located in News
Located in Newsroom / UNC Lineberger in the News
Located in Newsroom / UNC Lineberger in the News